Lima Memorial Health System Logo
Approximate ER WAIT TIME WAIT TIME MACRO

Health Library

Targeted therapies for cancer
     
Print-Friendly
Bookmarks

Targeted therapies for cancer

Molecularly targeted anticancer agents; MTAs; Chemotherapy-targeted; Vascular endothelial growth factor-targeted; VEGF-targeted; VEGFR-targeted; Tyrosine kinase inhibitor-targeted; TKI-targeted; Personalized medicine - cancer

 

Targeted therapy uses medicines to stop cancer from growing and spreading. It does this with less harm to normal cells than other treatments.

Information

 

Standard chemotherapy works by killing cancer cells but also damages or kills some normal cells. Targeted treatment zeroes in on specific targets (molecules) in or on cancer cells. These targets play a role in how cancer cells grow and survive. Using these targets, the medicine disables the cancer cells so they are less likely to spread.

 

How Does Targeted Therapy Work?

 

Targeted therapy medicines work in a few different ways. They may:

  • Turn off the process in cancer cells that causes them to grow and spread
  • Trigger cancer cells to die on their own
  • Kill cancer cells directly

People with the same type of cancer may have different targets in their cancer cells. So, if your cancer does not have a specific target, the medicine will not work to stop it. Not all therapies work for all people with cancer. At the same time, different cancers may have the same target.

To see if a targeted therapy might work for you, your health care provider may:

  • Take a tiny sample of your cancer
  • Test the sample for the specific targets (molecules)
  • Give you the treatment, if the right target is present in your cancer

Some targeted therapies are given as pills. Others are injected into a vein (intravenous, or IV).

 

Who May Get Targeted Therapy?

 

Targeted therapies can treat most types of cancers.

Your provider will decide whether targeted therapies may be an option for your type of cancer. You may receive targeted therapy along with surgery, chemotherapy, hormonal therapy, or radiation therapy. You may receive these medicines as part of your regular treatment, or as part of a clinical trial.

 

Side Effects

 

Providers thought that targeted therapies might have fewer side effects than other cancer treatments. But that turned out to be untrue. Possible side effects from targeted therapies include:

  • Diarrhea
  • Fatigue
  • Liver problems
  • Skin problems such as rash, dry skin, and nail changes
  • Problems with blood clotting and wound healing
  • High blood pressure

As with any treatment, you may or may not have side effects. They may be mild or severe. Fortunately, they usually go away after treatment ends. It is a good idea to talk with your provider about what to expect. Your provider may be able to help prevent or lessen some side effects.

 

Limitations

 

Targeted therapies are promising new treatments, but they have limitations.

  • Cancer cells can become resistant to these medicines.
  • The target sometimes changes, so the treatment no longer works.
  • The cancer may find a different way to grow and survive that does not depend on the target.
  • Medicines can be difficult to develop for some targets.
  • Targeted therapies are newer and cost more to make. So, they are more expensive than other cancer treatments.
  • The side effects may not be tolerated by some people.

 

 

References

Do KT, Kummar S. Therapeutic targeting of cancer cells: era of molecularly targeted agents. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 26.

Doroshow JH. Approach to the patient with cancer. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 164.

National Cancer Institute website. Targeted cancer therapies. www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Updated May 31, 2022. Accessed December 15, 2025.

BACK TO TOPText only

 

        A Closer Look

         

        Talking to your MD

         

          Self Care

           

            Tests for Targeted therapies for cancer

             
               

              Review Date: 10/21/2025

              Reviewed By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

              The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

              © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

              All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.
              © 1997- adam.comAll rights reserved.